Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tito Serafini | M | 60 | 14 years | |
| John Orwin | M | 62 | 6 years | |
| Jonathan Woo | M | - | 14 years | |
| Franklin Berger | M | 74 | 10 years | |
| Brian Atwood | M | 71 | 11 years | |
| William Robinson | M | 56 | 14 years | |
| David Lacey | M | 71 | 8 years | |
| Daniel Emerling | M | - | 14 years | |
| Lindsey Rolfe | M | 56 | 5 years | |
| Courtney Phillips | F | 49 | 5 years | |
| Rick Ruiz | M | - | 6 years | |
| John Campbell Robertson | M | 73 |
University of Cambridge
| 30 years |
| Gehan Anil Joseph Amaratunga | M | - |
University of Cambridge
| 28 years |
| Dame Dowling | M | 71 |
University of Cambridge
| 31 years |
| Alex Gray | M | - | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Louis Lavigne | M | 75 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Amit K Shah | M | - |
University of Cambridge
| 6 years |
| Robert Garnick | M | 74 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 24 years |
| Choon Wui Lim | M | 53 |
University of Cambridge
| 6 years |
| Erik Harris | M | 54 |
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Shen Yi Thio | M | 57 |
University of Cambridge
| 6 years |
| Michael Edward John Phelps | M | - |
University of Cambridge
| 5 years |
| Alexander Semenovich Vinokurov | M | 41 |
University of Cambridge
| 5 years |
| Herbert Cross | M | 52 | 4 years | |
| Mark Maybury | M | - |
University of Cambridge
| 5 years |
| Yann Chong Tan | M | - | - | |
| Wayne Volkmuth | M | - | 10 years | |
| Ewan Ellis Mellor | M | - |
University of Cambridge
| 3 years |
| Basil Lui | M | - |
University of Cambridge
| 4 years |
| Shuo Zhi Chen | M | - |
University of Cambridge
| 4 years |
| Sofia Maroudia | F | 47 |
University of Cambridge
| 7 years |
| Alessandra Cesano | M | 63 |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | 6 years |
| Sue Siegel | F | - |
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | 3 years |
| Jason Wulfsohn | M | 52 |
University of Cambridge
| 4 years |
| Cathy Bell-Walker | F | - |
University of Cambridge
| 5 years |
| Nicholas Taylor | M | 55 |
University of Cambridge
| 5 years |
| Edward King | M | 50 |
University of Cambridge
| 4 years |
| Xiao Hong Xi | M | 61 |
University of Cambridge
| 7 years |
| Gabrielle Walker | M | - |
University of Cambridge
| 7 years |
| Ka Fai Wong | M | 55 |
University of Cambridge
| 6 years |
| Zoe Nakash | F | - |
University of Cambridge
| 4 years |
| Lisa M. Kreiling | M | - |
University of Cambridge
| 5 years |
| Johnson Chen | M | 53 |
University of Cambridge
| 5 years |
| John Slater | M | 51 |
University of Cambridge
| 5 years |
| Ting Min Tan | F | 55 |
University of Cambridge
| 7 years |
| Kathy LaPorte | F | 62 |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | 2 years |
| Myrtle Potter | F | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
| Lawrence Steinman | M | 76 | 9 years | |
| Adrian John Cronje | M | - |
University of Cambridge
| 4 years |
| Andrew O'Neill | M | - |
University of Cambridge
| 3 years |
| Paulette A. Dillon | F | - | - | |
| Michael Varney | M | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 years |
| Ka-lai Cheng | F | 45 |
University of Cambridge
| 4 years |
| Simon Holden | M | 48 |
University of Cambridge
| 5 years |
| Jonathan Aberman | M | - |
University of Cambridge
| 8 years |
| Iain Kilty | M | - |
University of Cambridge
| 4 years |
| Philip Cowans | M | - |
University of Cambridge
| 8 years |
| Jeremy Tan | M | - |
University of Cambridge
| 3 years |
| James Ede-Golightly | M | 44 |
University of Cambridge
| 3 years |
| Sean Meyersfeld | M | - |
University of Cambridge
| 1 years |
| Steve Barnett | M | - |
University of Cambridge
| 4 years |
| Christine Ann Baalham | F | - |
University of Cambridge
| 1 years |
| Thomas Drummond | M | - |
University of Cambridge
| 4 years |
| Kwong Fai Mak | M | 52 |
University of Cambridge
| 4 years |
| Mark Mann | M | - |
University of Cambridge
| 4 years |
| Cyrille Fabre | M | - |
University of Cambridge
| - |
| Adam Ringer | M | - |
University of Cambridge
| 4 years |
| Tim Rule | M | - |
University of Cambridge
| 3 years |
| Anton Wellenreiter | M | - |
University of Cambridge
| 3 years |
| Sonny Bardhan | M | - |
University of Cambridge
| 4 years |
| Jennifer Suman | F | - |
University of Cambridge
| 3 years |
| Ben Catt | M | - |
University of Cambridge
| 3 years |
| Abdul Rahman bin Ahmad | M | 54 |
University of Cambridge
| 1 years |
| Rebecca Myers | M | - |
University of Cambridge
| 4 years |
| Simon Levell | M | - |
University of Cambridge
| 3 years |
| Rob Ryan | M | - |
University of Cambridge
| 3 years |
| Susan Mary McDonald | F | - |
University of Cambridge
| 3 years |
| Steven W. Wardell | M | - |
University of Cambridge
| 1 years |
| John Downing | M | 52 |
University of Cambridge
| 4 years |
| Suresh Narain Singh Sidhu | M | 56 |
University of Cambridge
| 4 years |
| Martin Hepworth | M | - |
University of Cambridge
| 4 years |
| Stephan Schulze | M | - |
University of Cambridge
| 1 years |
| Eliza Livadiotou | F | 50 |
University of Cambridge
| 4 years |
| Mio Takaoka | F | 45 |
University of Cambridge
| 3 years |
| Roderick Hafner | M | 58 |
University of Cambridge
| 3 years |
| Kai-Ulrich Deissner | M | 55 |
University of Cambridge
| 3 years |
| Tristram Julian Wi Hunt | M | 50 |
University of Cambridge
| 3 years |
| Kamarul Ariffin bin Mohammad Jamil | M | 55 |
University of Cambridge
| 4 years |
| Douglas R. Oppenheim | M | 48 |
University of Cambridge
| 3 years |
| Jonathan Sheldon | M | 52 |
University of Cambridge
| 3 years |
| Harry Seekings | M | 51 |
University of Cambridge
| 1 years |
| Gawn William Rowan Hamilton | M | - |
University of Cambridge
| 3 years |
| Qi Yan | M | - |
University of Cambridge
| 4 years |
| Aiden Lewis Bantin | M | - |
University of Cambridge
| 4 years |
| Nicholas Keveth | M | 55 |
University of Cambridge
| 4 years |
| Chris Barnes | M | - |
University of Cambridge
| 3 years |
| Sebastian Peck | M | - |
University of Cambridge
| 3 years |
| Mohammed Malik | M | 56 |
University of Cambridge
| 3 years |
| Adrian Woolfson | M | 60 |
University of Cambridge
| 4 years |
| Jason Gardner | M | 53 |
University of Cambridge
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 75 | 75.00% |
| United States | 25 | 25.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Guy Cavet
- Personal Network
